Acute exacerbations of chronic obstructive pulmonary disease are caused by a variety of different etiologies. The aim of the current study was to determine the diagnostic biomarkers for verifying the diagnosis of acute exacerbations of chronic obstructive pulmonary disease and predicting the length of hospital stay at elderly patients. The files of 120 patients who had been hospitalized with the diagnose of acute exacerbation of chronic obstructive pulmonary disease between January 2017 to December 2018 in the Chest Disease Department of Gulhane Education and Training Hospital were examined retrospectively. The numbers and the percentage of male and female patients were 83 (% 69) and 37 (% 31) respectively. Increases in the prohormone brain natriuretic peptide values of elderly patients were found as statistically significant (p<0.001). Statistically significant positive correlation between the lengths of hospital stay with the prohormone brain natriuretic peptide values was found at elderly patients group (r=0.336, p=0.001). Also statistically significant positive correlation was found between high sensitive C-reactive protein values with procalcitonin and neutrophil/ lymphocyte ratio (r=0.320, p=0.001 and r=0.257, p=0.006, respectively). Our study indicates significantly higher values of prohormone brain natriuretic peptide levels at elderly patients in accordance with length of hospital stay. These results would help us to consider the use of prohormone brain natriuretic peptide levels as a diagnostic biomarker for verifying the diagnosis of acute exacerbation of chronic obstructive pulmonary disease and predicting the length of hospital stay at elderly patients.
Introduction
Chronic obstructive pulmonary disease (COPD), one the worldwide public health problem, is thought to affect 384 million people with a globally prevalence of 11.7 percent and it is also predicted to become the most fourth leading cause of human deaths by 2030 [1, 2] . Acute exacerbation of COPD (AECOPD) is defined as the worsening period of the symptoms that reason the most of these patients enhancing their treatments [3] . The valid diagnostic test of AECOPD is not currently present, and only the health professionals' evaluation of patient symptoms and signs is used to diagnose of AECOPD [4] [5] [6] . COPD patients generally have a systemic inflammation that can be proofed with the high sensitive c-reactive protein (hs-CRP), interleukin (IL) and tumor necrosis factor alpha (TNF-alpha) [7] . However, the potential role of hs-CRP as a marker to reflect all aspects of pulmonary and extrapulmonary complications in COPD and its prognostic value in COPD need further investigation [8] [9] [10] [11] . Some measuring methods have made it possible to define the hs-CRP even at lower levels of inflammation [12] . B-type natriuretic peptide (BNP) and N-terminal fragment of prohormone-BNP (NT-pro-BNP) is derived from the pro-BNP. These are commonly used for diagnosis, risk stratification and management of hearth failure [13] . Since some receptor in various respiratory cells, such as type II alveolar cells and endothelial cells of pulmonary blood vessels is defined for BNP, the suggestion that BNP may modulate the respiratory system is becoming more acceptable. The exact mechanism is controversial but the experts claimed BNP/NTproBNP would be reliable biomarkers for the management of AECOPD patients [14] . COPD patients without hearth failure may have also high BNP [15] [16] [17] . Besides this, cytokines such as IL-1β, TNF-α, and IL-6 would be responsible for BNP secretion [18] . The possible strong predictor of AECOPD diagnosed patients admitted to hospital may be an elevated NT-proBNP value [19] . This inflammatory aspect of AECOPD would be estimated to impact both the pulmonary and cardiac systems. Currently, the number of the studies that evaluating both hs-CRP and pro-BNP values at AECOPD patients requiring hospitalization is increasing [20, 21] .
Defining the possible role of hs-CRP and pro-BNP as the diagnostic biomarkers for verifying the diagnosis of AECOPD and predicting the length of hospital stay (LOHS) at elderly patients was the preliminary goal of this current study.
Material and Methods
This descriptive cross-sectional sort of study was conducted at the AECOPD diagnosed patients that have hospitalized between January 2017 to December 2018 in the Chest Disease Department of Gulhane Education and Training Hospital. Involvement of the patients into the study with the diagnose of AECOPD by the chest diseases doctors was completed with the interpretation of patient's anamnesis, symptoms, physical examination findings and the biochemical analysis. According to these, a total of 163 patient files were evaluated retrospectively; 43 of these patients were excluded from the study due to additional cardiac diseases like congestive hearth failure, acute coronary disease and valvulary disease and non-pulmonary infectious diseases. And the total of 120 patients were included into the study. The files of 120 patients were analyzed according to the admission place, age, gender, body mass index, biochemical datas, preferentially hs-CRP, pro-BNP and the LOHS of the patients, retrospectively.
Statistical Analysis
Relationships of investigated parameters were evaluated statistically. SPSS for Mac 20.0 package program (SPSS Inc, Chicago, IL) was used for statistical evaluation. Data were summarized as the mean and standard deviation (SD) for the continuous variables, as absolute value and percentages for the categorical variables. The normality of the continuous variables was analyzed with the Kolmogorov-Smirnov test and Shapiro-Wilks test. Chi-square test for the categorical variables and Student's t-test or Mann-Whitney U statistical tests were used according to the suitability to the normal distribution for the continuous variables. In assessment of correlations, Spearman for data with non-parametric distribution was used. P-value less than 0.05 was considered as statistically significant with a 95% confidence interval.
Results
The fifty-five of one-houndred twenty patients included into the study had been diagnosed as AECOPD at the emergency service, and the rest sixty-five were at the polyclinic of Chest Diseases Department. The mean age of the patients was 68.9±7.9 years and the body mass index (BMI) was 25.6±3.9. The numbers of male and female patients were respectively 83 (%69) and 37 (%31). Mean ages of males and females were respectively 68.4±7.5 and 70.1±8.9 years and no statistically significant difference was found between them. Mean BMI of male and female patients were respectively 24.8±3.4 and 27.4±4.3, and there was a statistically significant difference between them (p=0.002). The values of hemoglobin (Hgb) and hematocrit (Hct) were found as lower at females (p<0.001) and the values of platelet (Plt) were found as lower at males (p=0.017), and all these were statistically significant. The statistically significant higher values of hs-CRP were found at male patients (p=0.005). A positive sided correlation between BMI with hgb (r=0.256, p=0.019) and BMI with htc (r=0.304, p=0.005) values were defined at male patients. All laboratory variables summarized in According to the ages, two groups were identified; First group patients whose ages were <65 years were called as non-elderly, and the second group patients whose ages were ≥65 years were called as elderly. The statistically significant higher proBNP values were found at elderly patients (p<0.001). The values of hgb (p=0.008), htc (p=0.015) and albumin (p=0.034) were found lower as statistically significant at elderly patients. There were positive sided correlations between the values of albumin with hgb (r=0.324, p=0.03) and htc (r=0.284, p=0.011) at elderly patients.
A statistically significant positive sided correlation between the values of pro-BNP with LOHS was found (r=0.336, p=0.001). However, no statistically significant correlation was found at LOHS between elderly with non-elderly patients, LOHS of elderly patients was found longer than non-elderly patients ( Table 2) . A statistically significant positive correlations between hs-CRP levels with procalcitonin (PCT) (r=0.320, p=0.001) and neutrophil/ lymphocyte ratio (NLR) were announced (r=0.257, p=0.006). 
Discussion
In the current study, the hs-CRP values were found as significantly higher at male patients. The consistent results from the studies by Alavi et al. [22] , Breyer et al. [23] and Kony et al. [24] were analyzed. The mean hs-CRP level in the study of Ghobadi H. et al. [25] was not significantly different between males and females. Previous study conducted by Bridevaux et al. [26] exhibited the more frequent increase of hs-CRP level and decrease of Forced Expiratory Volume 1 (FEV1] at females compared to males. In this study, there was neither ability to measure FEV1 of patients, and nor possibility to assess the relationship between exacerbation frequency with COPD stages.
Any correlation between BMI and COPD stages with hs-CRP levels was not found in the current study. At the study by Alavi et al. there was significantly correlation between hs-CRP with COPD patients stages, BMI, gender, tobacco habits and arterial carbondioxide pressure (PaCO2) at exacerbation state. The severity of COPD stages at male patients may be the reason of these patients' higher CRP levels [22] .
The positive sided correlation between BMI with hgb and htc values at male patients was detected in the current study. Some metabolic changes and muscle wasting at COPD patients would be responsible for higher inflammatory markers and hypermetabolic state. At the studies by Alavi et al., Bridevaux et al. and Pinto-Plata et al., the overweight and obese patients (measured by BMI) showed higher levels of CRP (as an inflammatory marker) than normal weighted patients [22, 26, 27] . The expectation that chronic inflammatory disease causes cachexia and weight loss is very common at COPD [28] . On the other hand, in a study in Ohio, Sahebjami and Sathianpitayakul discovered a correlation between dyspnea severity with lower weights. It can be argued that, as much as CRP level is correlated with the severity of COPD, the severe COPD (with higher levels of CRP) patients may become cachectic and thin [28] .
Any statistically significant correlation between smoking history of the patients with hs-CRP values was not detected in the current study. In Alavi et al.'s study, the more percentage of smokers showed higher risk levels of hs-CRP (p=0.043), but no significant difference between pack/year history with hs-CRP levels was announced (p=0.189) [22] . The consistent results with this were claimed at the studies of De Torres et al. and Halvani et al. (2006) [29] [30] [31] . Some genetic differences may be responsible for variability of inflammatory reaction development [27] .
The statistically significant higher pro-bnp values that are also consistent with published literatures were identified at elderly patients in our study [32, 33] . Renal failured patients also had elevated BNP concentrations [34] .
In Chen et al.'s study, the combined assesment of CRP and NT-proBNP in categorizing as outpatient or inpatient for AECOPD patients were evaluated. The combination approach was found more promising than the individual evaluation. This combination was also found significantly associated with mortality and LOHS. Although these results require more supportive clinical studies, the combination of biomarkers can potentially identify "severe" AECOPD patients and enable us to use more aggressive managements [33] .
At the consideration of correlations; positive sided statistically significant correlation between LOHS with the values of Pro-BNP at all patients especially at elderly patients was detected. There was also positive sided correlation between lower albumin levels with lower hgb and htc values at elderly patients in the current study.
Elevated NT-proBNP leveled patients had lower BMI and albumin levels and elevated BUN levels, more intensive care unit (ICU) requirement and LOHS [35, 36] .
AECOPD patients had different LOHS up to their illness severity and mechanical ventilation (MV) requirement [37] .
At the study by Hoiseth et al. the association between NT-pro-BNP and long-term mortality were emphasized besides the lack of 12% of the patients spirometrically COPD confirmation [38] .
The higher likelihood of ICU admission and longer LOHS were declared as associated with higher age-spesific NT-pro-BNP at Adrish et al's study. [39] .
The statistically significant positive correlation between hs-CRP with PCT and NLR was found in the current study. This result was consistent with Chen et al.'s study mentioning the correlation coefficient between CRP and NT-proBNP [33] .
Notwithstanding to Chen et al.'s study, the concentrations of two biomarkers (CRP and in particular NT-proBNP) were related to key outcome measures including length of hospital stay and mortality rate [33] .
Limitations
One of the important limitations of current study is absence of cardiological evaluation of patients before hospitalization, and the other one is the lack of the patients' control laboratory markers at discharge.
Conclusion
In the current study, the pro-BNP levels of the elderly patients were significantly higher than non-elderly patients'. And the higher proBNP level was found to be correlated positively with LOHS at all patients especially at elderly patients. On verifying the diagnose of AECOPD, the results are giving opinion that the increase of hs-CRP values must be evaluated with taking the patient's COPD stage, gender, anamnesis of exposure to air-pollution, BMI, smoking history, age, the exacerbation numbers of previous years, comorbidities and genetic features into the considerations.
As a conclusion, both hs-CRP and pro-BNP values were detected significantly increased at the patients having the diagnosis of AECOPD. A combinatorial measurement of these biomarkers could be helpful to categorize the patients to treat as outpatient or inpatient for optimal management of AECOPD patients.
